Autotaxin-IN-7
Autotaxin-IN-7 (45), a pyridine-2-carboxylic derivative, demonstrates subnanomolar ATX inhibition (IC50 = 0.086 nM), with a favorable heart safety profile (hERG > 30 μM) and minimal fibroblast toxicity. Autotaxin-IN-7 (45) suppresses the TGF-β/Smad signaling pathway, downregulating α-smooth muscle actin (α-SMA) and extracellular matrix components (ECM) . Autotaxin-IN-7 (45) is used in the research for pulmonary fibrosis[1].
Product Specifications
UNSPSC
12352005
Target
Phosphodiesterase (PDE) ; TGF-β Receptor
Related Pathways
Metabolic Enzyme/Protease; TGF-beta/Smad
Field of Research
Inflammation/Immunology
Smiles
O=C1N(C2=C(C3=C1N(C=C3C(NC4=CC=CC(C(O)=O)=N4)=O)C5=CN(N=C5)CCC)C=CC=C2)CC
Molecular Formula
C26H24N6O4
Molecular Weight
484.51
References & Citations
[1]Deyi Ma, et al. Development of Tricyclic 4,5-Dihydro-3 H-pyrrolo[2,3- c]quinolin-4-ones as Potent Autotaxin Inhibitors for Pulmonary Fibrosis Treatment In Vivo. J Med Chem. 2025 Apr 10;68 (7) :7476-7498.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400178-100 1x 100 µL
CD50 (ICAM-3) (186-2G9), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940050-100 1x 100 µL
IgA Secretory Component (SC05), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC051429-100 1x 100 µL
E-Cadherin / CD324 (Intercellular Junction Marker) (4A2), CF405M conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040270-100 1x 100 µL
Fibronectin (HFN7.1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details